-
2023-503666-23-00
5
2024-06-07
Neovascular age-related macular degeneration
-
2023-506054-20-00
5
2024-06-05
Adenocarcinoma of the biliary tract (intrahepatic or extrahepatic chol
-
2024-510966-18-00
4
2024-06-03
Relapsed or refractory indolent B-cell Non-Hodgkin Lymphoma (NHL)
-
2022-500571-32-00
4
2024-05-15
Early-Stage Unfavorable Classical Hodgkin Lymphoma
-
2023-505928-59-00
5
2024-04-15
Triple Negative or Hormone Receptor low/HER2-negative Breast Cancer
-
2024-517959-12-00
9
2024-04-11
Relapsed/refractory B cell precursor acute lymphoblastic leukemia
-
2022-502314-93-00
1
2024-02-05
MSIhi or dMMR advanced unresectable or metastatic solid tumors
-
2024-514458-61-01
4
2024-02-05
HER2+ early breast cancer
-
2023-503428-24-00
4
2024-01-19
Neoplasms, Head and Neck
-
2022-502110-85-00
5
2024-01-18
Peanut allergy
-
2022-501172-25-00
5
2024-01-17
Chronic and Episodic Migraine
-
2022-502975-45-00
5
2023-12-12
Metastatic leiomyosarcoma
-
2023-505160-12-00
5
2023-12-04
Essential Thrombocythaemia
-
2022-502789-26-01
4
2023-11-03
Fibrostenotic Crohn’s Disease
-
2023-504628-24-00
4
2023-10-31
Huntington's Disease
-
2023-503611-16-00
5
2023-09-29
Apheresis
-
2022-501644-15-01
4
2023-09-28
Mild Cognitive Impairment due to Alzheimer's Disease Alzheimer's Disea
-
2022-501346-30-00
5
2023-09-25
Newly Diagnosed Multiple Myeloma with Suboptimal Response After Autolo
-
2023-504028-24-00
5
2023-09-22
Large B-Cell Lymphoma
-
2024-515224-37-00
4
2023-08-29
Patients with MSI-high or MMR-deficient stage III colorectal cancer wh
-
2022-500758-41-00
1
2023-08-15
Amyotrophic lateral sclerosis
-
2022-501176-26-00
5
2023-08-04
Acute Ischemic Stroke and High-Risk Transient Ischemic Attack
-
2022-502922-41-00
5
2023-07-03
Obesity and overweight
-
2024-515027-11-00
4
2023-06-29
Crohn’s disease